A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics

Chest

Volumn 114, Issue 3, 1998, Pages 757-765

  Berkowitz, Robert ^a   Rachelefsky, Gary ^b   Harris, Alan G ^c   Chen, Rongdean ^c  

^a Atlanta Allergy and Immunology Research Foundation   (United States)

^b Allergy Research Foundation   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; SALBUTAMOL; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DYSPHONIA; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; THRUSH;

EID: 0031714136     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3.757     Document Type: Article

References (11)

1. Svendsen UG, Frølund L, Heinig JH, et al. High-dose inhaled steroids in the management of asthma: a comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and adrenal function. Allergy 1992; 47:174-180
2. Barnes N. Role of inhaled corticosteroids in the treatment of asthma. Respir Med 1994; 88(suppl A):1-4
3. National Heart, Lung, and Blood Institute. National Asthma Education Program, Office of Prevention, Education and Control. Expert panel report II: executive summary: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; April 1997; publication No. 97-4051
4. National Heart, Lung, and Blood Institute. International consensus report on diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; March 1992; publication No. 92-3091
5. Kamada AK, Szefler SI, Martin RJ, et al. Issues in the use of inhaled glucocorticoids. Respir Crit Care Med 1996; 153: 1739-1748
6. Weinberger M. Low- and high-dose therapy with aerosol steroids. In: Bone RC, Busse WW, Chapman KR, et al, eds. Current strategies for treating chronic bronchial asthma. New York: Forest Laboratories, 1990; 17-22
7. WHO drug dictionary. Uppsala, Sweden: WHO Collaborating Centre for International Drug Monitoring, 1995
8. National Heart, Lung, and Blood Institute. National Asthma Education Program, Office of Prevention, Education and Control. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda, Md: National Institutes of Health; August 1991; publication No. 91-3042
9. Data on file, Key Pharmaceuticals, Inc, Kenilworth, NJ
10. Newhouse MT. Pulmonary drug targeting with aerosols: principles and clinical applications in adults and children. Am J Asthma Allergy Pediatr 1993; 7:23-34
11. Johnson J. Pharmacodynamics and pharacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996; 97:169-176